Showing 1 - 2 results of 2 for search 'Rodolfo Cangiano', query time: 0.02s Refine Results
  1. 1
    Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

    Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis by Roberta Caputo, Giuseppe Buono, Michela Piezzo, Claudia Martinelli, Claudia Martinelli, Daniela Cianniello, Alessandro Rizzo, Francesco Pantano, Nicoletta Staropoli, Rodolfo Cangiano, Salvatore Turano, Ida Paris, Francesco Nuzzo, Alessandra Fabi, Michelino De Laurentiis

    Published 2024-03-01
    Get full text
    Article
  2. 2
    HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study

    HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results o... by Francesca Carlino, Anna Diana, Anna Ventriglia, Antonio Piccolo, Carmela Mocerino, Ferdinando Riccardi, Domenico Bilancia, Francesco Giotta, Giulio Antoniol, Vincenzo Famiglietti, Salvatore Feliciano, Rodolfo Cangiano, Lorenzo Lobianco, Benedetta Pellegrino, Ferdinando De Vita, Fortunato Ciardiello, Michele Orditura

    Published 2022-10-01
    Get full text
    Article

Search Tools: